E-LIB Suche - Ergebnisse für: Azze, Rolando Felipe Ochoa

1

A meningococcal B vaccine induces cross-protection against ..:

Azze, Rolando Felipe Ochoa
Clinical and Experimental Vaccine Research. 8 (2019) 2 - p. 110 , 2019

2

Immunogenicity of a new Salmonella Typhi Vi polysaccharide ..:

Azze, Rolando Felipe Ochoa ; Rodrı́guez, Juan Carlos Martı́nez ; Iniesta, Mónica Ginebra...
Vaccine. 21 (2003) 21-22 - p. 2758-2760 , 2003

Link: https://doi.org/10.1016/..

3

Los linfocitos Th1 no son exclusivos de la inmunidad celula:

Rolando Felipe Ochoa Azze
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2014000200001&lng=es&nrm=iso&tlng=es. , 2014

Link: https://doaj.org/article..

4

VA-MENGOC-BC®: XXV años de su aplicación masiva:

Rolando Felipe Ochoa Azze
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2013000100001&lng=es&nrm=iso&tlng=es. , 2013

Link: https://doaj.org/article..

5

VacciMonitor: 20 Aniversario:

Rolando Felipe Ochoa Azze
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2012000100001&lng=es&nrm=iso&tlng=es. , 2012

Link: https://doaj.org/article..

6

Jornada de Ciencias Básicas Médicas. Girón 2006:

Rolando Felipe Ochoa Azze
http://www.revhabanera.sld.cu/index.php/rhab/article/view/1348. , 2007

Link: https://doaj.org/article..

7

Cross-protection induced by VA-MENGOC-BC® vaccine:

Rolando Felipe Ochoa-Azze
http://dx.doi.org/10.1080/21645515.2018.1438028. , 2018

Link: https://doi.org/10.1080/..

8

El acceso a VacciMonitor puede hacerse a través de la Web o..:

Daniel Francisco Arencibia-Arrebola ; Rolando Felipe Ochoa-Azze
http://scielo.sld.cu/scielo.php?script=sci_pdf&pid=S1025-028X2014000300001&lng=es&nrm=iso&tlng=es. , 2015

Link: https://doaj.org/article..

9

Acknowledgment to the reviewers of VacciMonitor:

Daniel Francisco Arencibia-Arrebola ; Rolando Felipe Ochoa-Azze
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2015000100001&lng=es&nrm=iso. , 2015

Link: https://doaj.org/article..

10

Acknowledgment to the reviewers of VacciMonitor:

Daniel Francisco Arencibia-Arrebola ; Rolando Felipe Ochoa-Azze
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2015000100001&lng=es&nrm=iso&tlng=es. , 2015

Link: https://doaj.org/article..

11

Estudio bibliométrico de la producción científica de VacciM..:

Daniel Francisco Arencibia-Arrebola ; Virginia Betancourt-López ; Norka González-Alfalla...
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2014000200002&lng=es&nrm=iso. , 2014

Link: https://doaj.org/article..

12

Cross-protection induced by VA-MENGOC-BC® vaccine:

Ochoa-Azze, Rolando Felipe
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989903/. , 2018

Link: http://www.ncbi.nlm.nih...

13

A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD..:

Santana-Mederos, Darielys ; Perez-Nicado, Rocmira ; Climent, Yanet...
RSC Chemical Biology. 3 (2022) 2 - p. 242-249 , 2022

Link: https://doi.org/10.1039/..

14

A randomized, double-blind phase I clinical trial of two re..:

Pérez-Rodríguez, Sonia ; de la Caridad Rodríguez-González, Meiby ; Ochoa-Azze, Rolando...
Vaccine. 40 (2022) 13 - p. 2068-2075 , 2022

Link: https://doi.org/10.1016/..

15

A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances n..:

Chang-Monteagudo, Arturo ; Ochoa-Azze, Rolando ; Climent-Ruiz, Yanet...
The Lancet Regional Health - Americas. 4 (2021) - p. 100079 , 2021

Link: https://doi.org/10.1016/..